Total Payments
$9,192
2023 Payments
$567.08
Companies
34
Transactions
739
Medicare Patients
1,910
Medicare Billing
$219,749
Payment Breakdown by Category
Food & Beverage$8,590 (93.4%)
Other$581.72 (6.3%)
Education$20.76 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,590 | 733 | 93.4% |
| Entertainment | $581.72 | 4 | 6.3% |
| Education | $20.76 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,314 | 220 | $0 (2023) |
| AbbVie Inc. | $1,291 | 107 | $0 (2023) |
| Romark Laboratories, LC | $955.83 | 14 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $929.26 | 86 | $0 (2023) |
| QOL Medical, LLC | $618.44 | 83 | $0 (2023) |
| Janssen Biotech, Inc. | $492.66 | 36 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $300.24 | 23 | $0 (2023) |
| Celgene Corporation | $280.55 | 27 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $201.95 | 18 | $0 (2017) |
| Synergy Pharmaceuticals Inc | $190.02 | 18 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $567.08 | 41 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($156.58) |
| 2022 | $1,462 | 126 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($512.45) |
| 2021 | $1,599 | 147 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($806.99) |
| 2020 | $1,043 | 94 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($406.20) |
| 2019 | $1,229 | 119 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($277.00) |
| 2018 | $1,316 | 111 | Takeda Pharmaceuticals U.S.A., Inc. ($264.95) |
| 2017 | $1,976 | 101 | Romark Laboratories, LC ($643.96) |
All Payment Transactions
739 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Gastroenterology | ||||||
| 08/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Gastroenterology | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Gastroenterology | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: Gastroenterology | ||||||
| 06/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Gastroenterology | ||||||
| 06/13/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/13/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/31/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Gastroenterology | ||||||
| 05/24/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Gastroenterology | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Gastroenterology | ||||||
| 04/21/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Gastroenterology | ||||||
| 04/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Gastroenterology | ||||||
| 04/05/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: VIROLOGY | ||||||
| 04/04/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/04/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/28/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Gastroenterology | ||||||
| 03/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 225 | 238 | $162,689 | $24,196 |
| 2022 | 9 | 536 | 591 | $342,401 | $63,104 |
| 2021 | 8 | 609 | 671 | $377,452 | $71,576 |
| 2020 | 8 | 540 | 596 | $306,560 | $60,873 |
Total Patients
1,910
Total Services
2,096
Medicare Billing
$219,749
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $54,015 | $6,790 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 98 | $19,600 | $5,445 | 27.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $18,190 | $3,333 | 18.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 36 | $43,380 | $3,150 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 36 | $10,224 | $2,944 | 28.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $17,280 | $2,533 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 222 | $63,048 | $22,405 | 35.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 75 | 76 | $105,260 | $11,409 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 135 | $27,000 | $8,783 | 32.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 21 | $30,240 | $4,625 | 15.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 50 | $60,250 | $4,548 | 7.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 21 | 21 | $22,470 | $4,213 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $10,593 | $3,153 | 29.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $11,770 | $2,207 | 18.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $11,770 | $1,761 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 185 | $51,724 | $18,257 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 169 | $33,488 | $12,542 | 37.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 79 | 80 | $110,800 | $12,465 | 11.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 38 | 38 | $40,660 | $7,621 | 18.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 91 | 91 | $21,385 | $7,352 | 34.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 66 | 66 | $79,530 | $5,873 | 7.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 23 | 23 | $33,120 | $5,049 | 15.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,745 | $2,418 | 35.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 130 | 165 | $38,940 | $14,324 | 36.8% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 66 | 66 | $89,970 | $11,270 | 12.5% |
About Dr. Alex Celluzzi, DO
Dr. Alex Celluzzi, DO is a Gastroenterology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770583536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alex Celluzzi, DO has received a total of $9,192 in payments from pharmaceutical and medical device companies, with $567.08 received in 2023. These payments were reported across 739 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,590).
As a Medicare-enrolled provider, Celluzzi has provided services to 1,910 Medicare beneficiaries, totaling 2,096 services with total Medicare billing of $219,749. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Voorhees, NJ
- Active Since 07/22/2005
- Last Updated 07/11/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1770583536
Products in Payments
- XIFAXAN (Drug) $1,851
- Alinia Tablets 500mg 30 count bottle (Drug) $804.17
- Sucraid (Drug) $556.97
- STELARA (Biological) $461.84
- Amitiza (Drug) $444.86
- TRULANCE (Drug) $326.84
- Linzess (Drug) $300.24
- ENTYVIO (Biological) $295.63
- Humira (Biological) $281.87
- ZEPOSIA (Drug) $280.55
- HUMIRA (Biological) $235.46
- Creon (Drug) $213.72
- MOTEGRITY (Drug) $213.10
- Trulance (Drug) $190.02
- Mavyret (Drug) $163.19
- DUPIXENT (Biological) $150.29
- MAVYRET (Drug) $146.42
- LINZESS (Drug) $138.25
- Alinia (Drug) $121.79
- VIBERZI (Drug) $108.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Voorhees
Dr. Sanket Patel, D.o, D.O
Gastroenterology — Payments: $39,650
Gastroenterology $39,650
Dr. Alan Mushnick, Md, MD
Gastroenterology — Payments: $26,516
Gastroenterology $26,516
Elizabeth Egan, Md, MD
Gastroenterology — Payments: $10,600
Gastroenterology $10,600
Dr. Michael Goldstein, Md, MD
Gastroenterology — Payments: $10,508
Gastroenterology $10,508
Andrew Alloy, Do, DO
Gastroenterology — Payments: $9,041
Gastroenterology $9,041
Christopher Morrison, M.d, M.D
Gastroenterology — Payments: $7,129
Gastroenterology $7,129